Roche Holding AG Dividend Right Cert. (CHF)
ROG
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range332.70 | 343.65
52-Wk Range- | -
Last Close332.70
Mkt Cap (m)285,078.17
Dividend yield2.71
ISINCH0012032048
Volume2,770,053.00
Exchange VenueSWX

Company Profile

Roche Holding AG is a pharmaceutical and diagnostic company. It specializes in medicines for oncology, virology, inflammation, metabolism, clinical chemistry, immunology, urinalysis, blood screening, genetics, infectious diseases, and microbiology.

Key Information
Price/Earning21.30
Price/Book8.70
Price/Sales4.68
P/CF12.84
Rev Growth (3 year avg)6.72
EPS Growth (3 year avg)0.12
Operating Margin % 28.55
Net Margin %21.96
Return on Equity44.72
Debt/Equity0.48

Documents

Annual Report
en 31/12/2019

Financials

Income Statement
CHF201420152016201720182019
Revenue (m)47,462.0048,145.0050,576.0053,299.0056,846.0061,466.00
Operating Income (m)14,090.0013,821.0014,069.0013,003.0014,743.0017,548.00
Net Income (m)9,332.008,863.009,576.008,633.0010,500.0013,497.00
Basic EPS10.9910.4211.2410.1212.2915.77
Avg. Diluted Shares Outstanding (m)863.00862.00860.00860.00860.00864.00
Balance Sheet
CHF201420152016201720182019
Current Assets (m)31,114.0028,182.0028,670.0031,572.0032,244.0031,254.00
Non Current Assets (m)44,527.0047,581.0048,149.0045,104.0046,273.0051,837.00
Total Assets (m)75,641.0075,763.0076,819.0076,676.0078,517.0083,091.00
Current Liabilities (m)23,108.0023,768.0022,600.0022,160.0023,033.0024,119.00
Total Liabilities (m)------
Total Equity (m)19,586.0020,979.0023,911.0026,441.0027,622.0032,747.00
Cash Flows
CHF201420152016201720182019
Operating Cash Flows (m)15,930.0015,251.0015,001.0018,024.0019,979.0022,385.00
Capital Expenditure (m)-3,334.00-4,110.00-5,145.00-4,213.00-4,922.00-4,896.00
Figures are quoted in CHF unless stated otherwise
-
No change
332.70
Last Price